Physician profile
Sandra Limon
NPI 1316493406
$1,035.06
in general payments reported to CMS, 2019-2025
13 companies · $324 in 2025
The $324 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $239 · 2023: $181 · 2024: $291 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $796.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $795.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $286.77 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Abbott Laboratories | $191.28 | 2022-2023 | Freestyle Libre 3 |
| Lilly USA, LLC | $185.97 | 2022-2025 | Mounjaro |
| Merck Sharp & Dohme LLC | $77.23 | 2022-2025 | Vaxneuvance, Gardasil 9, Enflonsia |
| Hologic Sales and Service, LLC | $75.07 | 2023-2024 | Aptima, Thinprep 2000 Processor |
| Pfizer INC. | $39.69 | 2023-2024 | |
| Exact Sciences Corporation | $39.57 | 2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $33.84 | 2023-2025 | Breztri |
| Phadia US INC. | $27.91 | 2023-2024 | Immunocap |
| Dexcom, INC. | $22.02 | 2025 | Dexcom G6 Transmitter |
| Biohaven Pharmaceutical Holding Company LTD. | $21.81 | 2022 | |
| Chiesi USA, INC. | $21.65 | 2023 | Kengreal, Cleviprex |
| Electromed, INC. | $12.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Limon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.